Andres Forero, M.D., professor of hematology/oncology and senior scientist in the UAB Comprehensive Cancer Center
• Leading national trial of tigatuzumab, a monoclonal antibody developed at UAB
• Member, breast cancer panel, National Comprehensive Cancer Network
• Recipient of $6.5 million Susan G. Komen for the Cure Promise Grant
• Experimental therapeutics program co-leader
Selected media appearances:
(CBS 42) UAB doctor talks about controversial breast cancer drug
(Medical News Today) Experimental drug shows promise In treating one class of lymphoma
(Birmingham Medical News) Birmingham researchers work on promising cancer drugs
Back to experts guide
